DoP seeks MHA intervention for uninterrupted pharma
- Classification:Chemical Auxiliary Agent
- CAS No.:117-84-0
- Other Names:DOP, diocty phthalate, 1,2-phthalate
- MF:C24H38O4, C24H38O4
- EINECS No.:201-557-4
- Purity:99%min
- Type:pvc additive
- Usage:Leather Auxiliary Agents, Paper Chemicals, Plastic Auxiliary Agents, Rubber Auxiliary Agents, Textile Auxiliary Agents
- MOQ:200kgs
- Package:200kgs/battle
- Volume Resistivity:741
- Item:T/T,L/C
Due to nationwide lockdown because of Coronavirus (Covid-19), apart from challenges in transportation and availability of workforce, there are two major issues; ancillary
Express Pharma Express Pharma. Home
DoP asks pharma associations to provide ancillary units list
- Classification:Chemical Auxiliary Agent
- CAS No.:117-84-0
- Other Names:DOP Bis(2-ethylhexyl) phthalate
- MF:C24H38O4, C24H38O4
- EINECS No.:201-557-4
- Purity:99%min
- Type:Adsorbent, Carbon Black
- Usage:Coating Auxiliary Agents, Leather Auxiliary Agents, Petroleum Additives, Plastic Auxiliary Agents, Rubber Auxiliary Agents, Surfactants, Textile Auxiliary Agents
- MOQ::10 Tons
- Package:25kg/drum
- Shape:Powder
- Model:Dop Oil For Pvc
- Storage:Dry Place
DoP asks pharma associations to provide ancillary units list, uninterrupted pharma supplies Associations have asked member companies to submit the requested data on a priority basis
Express Pharma Express Pharma. Home
Ancillary Supplies Clinical Trial Must-Haves that Require
- Classification:Chemical Auxiliary Agent
- CAS No.:117-84-0
- Other Names:Dioctyl Phthalate
- MF:C24H38O4
- EINECS No.:201-557-4
- Purity:99%, 99%
- Type:Adsorbent
- Usage:Plastic Auxiliary Agents, Plasticizer
- MOQ::10 Tons
- Package:25kg/drum
- Item:T/T,L/C
In this article, Janet Williams, senior director, global supply chain management, and Julie Hoffman, senior director of commercial strategy and execution, discuss why ancillaries are as
EXECUTIVE SUMMARY (1/2) 2 The success of ~$41 Bn Pharma industry is driven by a network of Ancillary Partnerships • The pharma industry is a jewel in India‘s crown with long term
The Cost of Overlooking Ancillary Supplies in Protocol
- Classification:Chemical Auxiliary Agent, Chemical Auxiliary Agent
- cas no 117-84-0
- Other Names:DOP, Dioctyl phthalate
- MF:C24H38O4, C24H38O4
- EINECS No.:201-557-4
- Purity:99%
- Type:Carbon Black
- Usage:Plastic Auxiliary Agents
- MOQ:200kgs
- Package:200kgs/battle
- Shape:Powder
That level of foresight is now necessary for all trials. Sourcing ancillary supplies should be part of the conversation from the beginning, and protocols should match what the
With group purchasing at the core of our diversified offerings, Managed Health Care Associates, Inc. (MHA) negotiates with more than 600 manufacturers and suppliers to provide over 900
The Drivers of Success in Ancillary Supply Chain
- Classification:Chemical Auxiliary Agent, Chemical Auxiliary Agent
- cas no 117-84-0
- Other Names:Dop
- MF:C24H38O4, C24H38O4
- EINECS No.:201-557-4
- Purity:99.5% min.
- Type:Liquid, plasticizer
- Usage:Leather Auxiliary Agents, Paper Chemicals, Petroleum Additives, Plastic Auxiliary Agents, Rubber Auxiliary Agents, Textile Auxiliary Agents, Leather Auxiliary Agent,Plastic Auxiliary Agent,
- MOQ:200kgs
- Package:200kgs/battle
- Shape:Powder
- Shape:Powder
- Model:Dop Oil For Pvc
The clinical trial ancillary supply chain (CTASC) a global, extremely complex, highly variable, unregulated, and decentralised system manages the flow of non-drug materials to sites for
Express Pharma Express Pharma. Home. Drug approvals; Nutraceuticals; Pharma IT; Policies; Technology
- Should Pharma organisations outsource ancillary supplies distribution?
- Pharma organisations have elected to outsource requirements for ancillary supplies distribution (medical devices, laboratory equipment, patient supplies, etc.) to preferred partners that manage the chain via an integrated, end-to-end process.
- Why are ancillary supplies important in clinical trials?
- Ancillary supplies are a necessary component in every clinical trial, though these products are often perceived as secondary in importance to investigational medicinal products (IMPs).
- What is Accenture's methodology for identifying Pharma interventions?
- The methodology for identifying these interventions is interactive - through IPA‘s and CRISIL‘s facilitation, Accenture has conducted several interviews across large Indian pharma manufacturers, pharma ancillaries and industry SMEs to develop a holistic perspective.
- Are ancillaries a challenge for IPA & Accenture?
- These challenges are further compounded by the limited visibility industry stakeholders have into ancillaries. IPA and Accenture recognized that urgent action is required to support the ancillaries and therefore collaborated to identify interventions that will enable business recovery.